EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 3.0

Misclassification and Circular Inference Undermine the Reported NATALEE Benchmark [Letter]

Xin Zhou

Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-2

DOI: 10.2147/dddt.s666928 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Xin Zhou. Beteiligte Einrichtung: Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xin ZhouDepartment of Chemoradiotherapy, The Affiliated People’s Hospital of Ningbo University, Ningbo, People’s Republic of ChinaCorrespondence: Xin Zhou, The Affiliated People’s Hospital of Ningbo University, Ningbo, Zhejiang, People’s Republic of China, Email Zhou_TF1217@126.com

Autor:innen und Institutionen

  • Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.

Zitieren

APA

Zhou, X. (2026). Misclassification and Circular Inference Undermine the Reported NATALEE Benchmark [Letter]. Drug Design, Development and Therapy, Volume 20, 1-2. https://doi.org/10.2147/dddt.s666928

Vancouver

Zhou X. Misclassification and Circular Inference Undermine the Reported NATALEE Benchmark [Letter]. Drug Design, Development and Therapy. 2026;Volume 20:1-2. doi:10.2147/dddt.s666928

BibTeX
@article{Zhou2026,
  author = {Zhou, Xin},
  title = {Misclassification and Circular Inference Undermine the Reported NATALEE Benchmark [Letter]},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--2},
  doi = {10.2147/dddt.s666928}
}
Kostenlos starten →